Navigation Links
CVS Caremark Insights 2011 Report Highlights Lowest Drug Trend in Six Years and Increased Utilization of Generics
Date:4/14/2011

WOONSOCKET, R.I., April 14, 2011 /PRNewswire/ -- CVS Caremark (NYSE: CVS) today released its annual Insights Report, which reviews drug trend and highlights key areas to watch in pharmacy care.  In 2010, the average drug trend for the company's pharmacy benefit management (PBM) client segments -- employers, health plans and third party administrators -- was 2.4 percent, the lowest trend in six years, demonstrating that CVS Caremark helped its clients and their members effectively manage pharmacy costs during a tough economic year.

(Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO)

"Last year was one of uncertainty and change for our clients as they worked to understand the impact of health care reform while also dealing with a sluggish economic recovery," said Per Lofberg, president of CVS Caremark's pharmacy benefit management business.  "One of our priorities is to help our clients navigate health care reform and determine how best to implement necessary changes.  Even with this added layer of complexity, we helped our clients manage costs and maintain quality care for their members."

The company's 2010 drug trend was held in check by the increasing use of generics as more of these less expensive medications became available, more physicians prescribed them and more members were willing to use generics. The company's generic dispensing rate (GDR) was 71.5 percent.  Other trend drivers included continued growth in the utilization of complex specialty pharmaceuticals, as well as an increase in utilization of prescription drugs overall.  CVS Caremark anticipates these trends will continue this year and, when coupled with the growing impact of chronic disease, sees a need to integrate and coordinate pharmacy care in a centralized location -- a pharmacy home -- to  help members coordinate and simplify  their medication management.

In addition to the 2.4 percent overall trend, the more notable 2011 Insights findings are:

  • Non-specialty trend -- the cost increase for prescriptions excluding expensive biologic pharmaceuticals -- was .8 percent, driven by the increased use of generics.
  • Specialty pharmaceuticals continued to be the fastest growing area of spending in medications, increasing 13.7 percent from the year before.  
  • About one-quarter of the CVS Caremark clients experienced a reduction in medication costs year-over-year, or a negative trend; one-third of the clients experienced a trend of less than 2.5 percent.

  • "The continuing increase in the use of expensive specialty drugs, as well as the growing prevalence of chronic disease, calls for innovative health care solutions such as an integrated pharmacy home to help patients deal with complex therapy regimens and stay adherent," says Troyen A. Brennan, MD, MPH, Executive Vice President and Chief Medical Officer of CVS Caremark.  "Developing a pharmacy home was one of the recommendations raised by our recent research conducted with Harvard Medical School and Brigham & Women's Hospital. That work and this report make it clear we must devise better ways to serve the chronically ill. This trend report shows we are making headway in that fight."

    CVS Caremark programs that maximize the benefits of the integrated enterprise have already been embraced by the company's PBM clients and their members. For example, Maintenance Choice provides members with two options for receiving 90-day supplies of maintenance medications for chronic conditions, either by using a convenient mail order pharmacy or by maintaining their face-to-face connection with their local CVS pharmacist, while paying less out-of-pocket for their medications.  In addition, the recently launched Pharmacy Advisor program enables members with diabetes to build a relationship with their mail order pharmacist or local CVS pharmacist, providing information and support that closes gaps in care, can reduce costs and promotes mediation adherence.

    Access the full 2011 Insights Report in the publication section at the following link: http://www.cvscaremark.com/files/reports/Insights2011.pdf

    About CVS CaremarkCVS Caremark is the largest pharmacy health care provider in the United States with integrated offerings across the entire spectrum of pharmacy care. We are uniquely positioned to engage plan members in behaviors that improve their health and to lower overall health care costs for health plans, plan sponsors and their members. CVS Caremark is a market leader in mail order pharmacy, retail pharmacy, specialty pharmacy, and retail clinics, and is a leading provider of Medicare Part D Prescription Drug Plans. As one of the country's largest pharmacy benefits managers (PBMs), we provide access to a network of approximately 65,000 pharmacies, including more than 7,100 CVS/pharmacy® stores that provide unparalleled service and capabilities. Our clinical offerings include our signature Pharmacy Advisor™ program as well as innovative generic step therapy and genetic benefit management programs that promote more cost effective and healthier behaviors and improve health care outcomes. General information about CVS Caremark is available through the Company's Web site at http://info.cvscaremark.com/. Media Contact:Christine Cramer

    Sara SteindorfCVS Caremark

    Weber Shandwick(401)770 3317

    (617)520-7259ckcramer@cvs.com

    ssteindorf@webershandwick.com
    '/>"/>

    SOURCE CVS Caremark
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. CVS Caremark Named One of Americas Most Reputable Companies by Reputation Institute
    2. CVS Caremark Research Finds "Dispense as Written" Prescriptions May Add $7.7 Billion to Annual Health Care Costs
    3. CVS Caremark Charitable Trust Makes Initial Donation of $100,000 to Relief Effort in Japan
    4. CVS Caremark Announces Agreement With ActiveHealth Management for Evidence-Based Clinical Decision Support
    5. CVS Caremark and Universal American Announce Termination of Hart-Scott-Rodino Waiting Period
    6. CVS Caremark Awarded Pharmacy Benefit Management Institute Rx Benefit Innovation Award for Pharmacy Advisor Program
    7. CVS Caremark Corporation to Hold Fourth Quarter 2010 Conference Call
    8. CVS Caremark Study Evaluates Which Pharmacy Channel Consumers Choose When Given Choice of Mail or Retail Prescriptions
    9. CVS Caremark Announces Interim Leadership for Retail Business
    10. CVS Caremark Study Finds Patients with Complex Therapies Struggle to Stay Adherent to their Medications
    11. CVS Caremark Study Finds Medication Adherence Leads to Lower Health Care Costs, Even After Accounting for Increased Prescription Drug Spending
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/24/2016)... OAKLAND, N.J. , June 24, 2016 /PRNewswire/ ... in the design, development and manufacturing of collagen ... and regeneration announced today that Bill Messer ... Sales and Marketing to further leverage the growing ... surgery medical devices. Bill joins the ...
    (Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
    (Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
    Breaking Medicine Technology:
    (Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
    (Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
    (Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
    (Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
    (Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
    Breaking Medicine News(10 mins):